MGNX
Price:
$1.38
Market Cap:
$87.30M
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The company's pipeline of immuno-oncology product candidates includes MGC018, an antibody drug conjugate (ADC), which targets solid tumors expressing B7-H3; Enoblituzumab, a monoclonal antibody that targets B7-H3; and MGD024, an investigational bispecif...[Read more]
Industry
Biotechnology
IPO Date
2013-10-10
Stock Exchange
NASDAQ
Ticker
MGNX
According to MacroGenics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 44.18M. This represents a change of 20.76% compared to the average of 36.58M of the last 4 quarters.
The mean historical Enterprise Value of MacroGenics, Inc. over the last ten years is 545.75M. The current 44.18M Enterprise Value has changed 709.48% with respect to the historical average. Over the past ten years (40 quarters), MGNX's Enterprise Value was at its highest in in the March 2021 quarter at 1.62B. The Enterprise Value was at its lowest in in the March 2025 quarter at -28137922.95.
Average
545.75M
Median
501.58M
Minimum
58.14M
Maximum
1.05B
Discovering the peaks and valleys of MacroGenics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 145.05%
Maximum Annual Enterprise Value = 1.05B
Minimum Annual Increase = -89.00%
Minimum Annual Enterprise Value = 58.14M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 58.14M | -89.00% |
| 2023 | 528.77M | 56.42% |
| 2022 | 338.04M | -60.88% |
| 2021 | 864.11M | -17.46% |
| 2020 | 1.05B | 145.05% |
| 2019 | 427.24M | 42.59% |
| 2018 | 299.62M | -36.84% |
| 2017 | 474.38M | -24.31% |
| 2016 | 626.76M | -21.01% |
| 2015 | 793.44M | -2.06% |
The current Enterprise Value of MacroGenics, Inc. (MGNX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
308.32M
5-year avg
567.20M
10-year avg
545.75M
MacroGenics, Inc.’s Enterprise Value is less than Ovid Therapeutics Inc. (96.01M), greater than Context Therapeutics Inc. (11.29M), less than Clene Inc. (72.09M), greater than Whitehawk Therapeutics Inc (-24287393.00), less than Shattuck Labs, Inc. (101.48M), less than Connect Biopharma Holdings Limited (102.22M), less than Oramed Pharmaceuticals Inc. (98.45M), less than Zentalis Pharmaceuticals, Inc. (101.24M), greater than Coya Therapeutics, Inc. (-29657635354.00), less than InflaRx N.V. (51.57M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 96.01M | $115.21M | |
| 11.29M | $94.64M | |
| 72.09M | $58.52M | |
| -24287393.00 | $120.65M | |
| 101.48M | $142.27M | |
| 102.22M | $141.98M | |
| 98.45M | $113.33M | |
| 101.24M | $101.15M | |
| -29657635354.00 | $99.69M | |
| 51.57M | $74.52M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MacroGenics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MacroGenics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is MacroGenics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for MacroGenics, Inc. (MGNX)?
What is the 3-year average Enterprise Value for MacroGenics, Inc. (MGNX)?
What is the 5-year average Enterprise Value for MacroGenics, Inc. (MGNX)?
How does the current Enterprise Value for MacroGenics, Inc. (MGNX) compare to its historical average?